Abstract
Patients with obstructive sleep apnea are at greater risk of cardiovascular morbidity and mortality. The prevalence of obstructive sleep apnea also seems to be higher in patients with cardiovascular conditions. Obstructive sleep apnea and coronary artery disease share some common risk factors while the pathophysiological interaction between them includes neural, humoral, mechanical and hemodynamic components. In this review we focus on the association between obstructive sleep apnea and coronary disease on the basis of their pathophysiological interaction, inflammatory mechanisms and to the effects of sleep apnea therapy on coronary disease outcomes.
Keywords: Obstructive sleep apnea, coronary heart disease, cardiovascular risk, systemic inflammation.
Current Respiratory Medicine Reviews
Title:Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further
Volume: 11 Issue: 4
Author(s): Andriana I. Papaioannou, Konstantinos Kostikas and Spyros Papiris
Affiliation:
Keywords: Obstructive sleep apnea, coronary heart disease, cardiovascular risk, systemic inflammation.
Abstract: Patients with obstructive sleep apnea are at greater risk of cardiovascular morbidity and mortality. The prevalence of obstructive sleep apnea also seems to be higher in patients with cardiovascular conditions. Obstructive sleep apnea and coronary artery disease share some common risk factors while the pathophysiological interaction between them includes neural, humoral, mechanical and hemodynamic components. In this review we focus on the association between obstructive sleep apnea and coronary disease on the basis of their pathophysiological interaction, inflammatory mechanisms and to the effects of sleep apnea therapy on coronary disease outcomes.
Export Options
About this article
Cite this article as:
Papaioannou I. Andriana, Kostikas Konstantinos and Papiris Spyros, Sleep Apnea and Coronary Heart Disease: From Dusk Till Dawn and Further, Current Respiratory Medicine Reviews 2015; 11 (4) . https://dx.doi.org/10.2174/1573398X11666150915212917
DOI https://dx.doi.org/10.2174/1573398X11666150915212917 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Chronic obstructive pulmonary disease (COPD) from childhood to adulthood: from the past to the future
Chronic obstructive pulmonary disease (COPD) is one of the three leading causes of death worldwide, with a major prevalence in low- and middle-income countries, resulting in a high social and economic cost. It is a heterogeneous respiratory disease, treatable and preventable, that causes persistent and often progressive airway obstruction in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anesthetic Pharmacology and Perioperative Considerations for the End Stage Liver Disease Patient
Current Clinical Pharmacology Metabolic Syndrome and Asthma
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Heat Shock Response Regulates Insulin Sensitivity and Glucose Homeostasis: Pathophysiological Impact and Therapeutic Potential
Current Diabetes Reviews Assessment of Circulating CCR6 Level in Acute Myocardial Infarction and its Association with Disease Severity
Cardiovascular & Hematological Agents in Medicinal Chemistry Diabetes Therapy: Novel Patents Targeting the Glucose-Induced Insulin Secretion
Recent Patents on DNA & Gene Sequences Antisense Oligonucleotides for the Treatment of Dyslipidemia
Current Pharmaceutical Design Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk
Current Vascular Pharmacology Urocortins: Putative Role in Cardiovascular Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design Animal Models of Carcinogenesis in Inflamed Colorectum: Potential Use in Chemoprevention Study
Current Drug Targets The Role of Metabolizing Enzymes and Transporters in Antiretroviral Therapy
Current Topics in Medicinal Chemistry Coagulopathy in Type 2 Diabetes Mellitus: Pathological Mechanisms and the Role of Factor XIII-A Single Nucleotide Polymorphisms
Current Diabetes Reviews Bioengineering RNA Silencing Across the Life Kingdoms
Recent Patents on Biotechnology Supplementation of Creatine and Ribose Prevents Apoptosis and Right Ventricle Hypertrophy in Hypoxic Hearts
Current Pharmaceutical Design Immunomodulatory Activity of Garlic
Current Immunology Reviews (Discontinued) A Combination of 3D-QSAR Modeling and Molecular Docking Approach for the Discovery of Potential HIF Prolyl Hydroxylase Inhibitors
Medicinal Chemistry Omega-3 Fatty Acids Supplementation in Psychiatric Disorders: A Systematic Review
Current Psychopharmacology Utilization of Proven Therapies for Chronic Obstructive Lung Disease (COPD) in Patients with Alpha-1 Antitrypsin Deficiency
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses
Current Alzheimer Research